Story preview
Topics in this story
Continue reading on the publisher site for the full article.
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Context from Wikipedia on the organisations, people and places in this story.
Swiss pharmaceutical company
Galderma S.A. is a Swiss pharmaceutical company based in Zug that specializes in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé, it was acquired by a consortium of private institutional investors in 2019 and remained under their ownership until its initial public offering in 2024. It has been a component of the Swiss Market Index since September 2026.
More on Wikipedia ↗Outlets covering it
12
in the last 3 days
First reported
3 days ago
11 outlets since
Countries
11 other outlets reported this story in the last 3 days.
Blackstone (BX) has agreed to sell ZO Skin Health for $1.5 billion to Galderma, the buyer said Wedne
Blackstone (NYSE:BX) agreed to sell ZO Skin Health to Galderma for US$1.5b in cash, as announced in October 2026. AirTrunk, backed by Blackstone, postponed its planned US$1.5b IPO to 2027, citing market volatility for the delay. Firmus Technologies may be required to repurchase shares from Blackstone and Nvidia if its…
Blackstone funds set to exit ZO Skin Health in $1.5 billion Galderma deal